Novel prediction tool accurately determines disease stage
A new learning-based framework enables patients and caregivers to predict the timing of any of the five clinical groups of AD development.
List view / Grid view
A new learning-based framework enables patients and caregivers to predict the timing of any of the five clinical groups of AD development.
The guide provides examples of how Transcreener allowed rapid assay development to enable screening for kinases in innate immune pathways.
The ML algorithm explores how genetic mutations collectively influence a tumour’s reaction to drugs impeding DNA replication.
New software can make protein molecules that bind with high affinity and specificity to many biomarkers, including human hormones.
A new deep-learning method could enhance therapeutic devices for people with neurological or mental health conditions.
An AI system could be used to observe how physical constraints shape brains and impact people with cognitive difficulties.
Researchers, using high-resolution mapping and mathematical modelling, have found mechanisms controlling mutation-driven diseases.
An advanced computational model enables scientists to study how cancer cells navigate through blood vessels.
Combining cancerous and non-cancerous cell patterns, the AI model evaluates breast cancer outcomes better than expert pathologists.
Researchers have developed an AI based model that is 80 percent accurate in predicting the therapy outcome of high-grade ovarian cancer.
Percent necrosis calculated with machine learning model for patients with osteosarcoma provides an accurate prognosis for survival.
Tune into this podcast to understand why researchers are turning to 3D Organoids and how organoids can be made ready for screening.
29 September 2023 | By Analytik Jena
Watch this webinar to learn how PROTACs are revolutionising drug discovery, and the critical role protein purification plays in the production of therapeutic proteins.
This ebook outlines Euretos’ approach to target discovery and indication expansion. Whilst also discussing data-driven target selection.
A new Drug Target Review issue is now ready to download! This issue features articles on vaccine development, artificial intelligence and organoids.